Brief: Minerva Neurosciences - Cash, Cash Equivalents And Restricted Cash At September 30, 2023, Were Approximately $47.0 Million
Nov 7 (Reuters) - Minerva Neurosciences Inc NERV.O :
* MINERVA NEUROSCIENCES INC - CASH, CASH EQUIVALENTS AND
RESTRICTED CASH AT SEPTEMBER 30, 2023, WERE APPROXIMATELY $47.0
MILLION
Source text for Eikon: ID:nGNE7hR53J
Further company coverage: NERV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Minerva Neurosciences
See all newsU.S. RESEARCH ROUNDUP-Cisco, Fox Corp, Target
Brief: Minerva Neurosciences Provides Second Quarter 2026 Financial Results And Business Updates
Brief: Minerva Neurosciences - To Offer And Sell Up To $75 Million In Common Stock Through Leerink Partners
Brief: Minerva Announces Leadership Transition
Minerva Neurosciences Q4 net loss widens on non-cash financing charges